Financial Advantage’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,000
Closed -$86K 89
2022
Q3
$86K Hold
1,000
0.08% 47
2022
Q2
$91K Hold
1,000
0.08% 52
2022
Q1
$82K Buy
1,000
+972
+3,471% +$76.6K 0.07% 57
2021
Q4
$2K Hold
28
﹤0.01% 128
2021
Q3
$2K Hold
28
﹤0.01% 115
2021
Q2
$2K Sell
28
-1
-3% -$74 ﹤0.01% 112
2021
Q1
$2K Hold
29
﹤0.01% 127
2020
Q4
$2K Hold
29
﹤0.01% 115
2020
Q3
$2K Sell
29
-83
-74% -$6.5K ﹤0.01% 102
2020
Q2
$8K Hold
112
0.01% 132
2020
Q1
$8K Hold
112
0.01% 94
2019
Q4
$9K Sell
112
-132
-54% -$10.8K 0.01% 91
2019
Q3
$19K Hold
244
0.01% 117
2019
Q2
$19K Hold
244
0.01% 78
2019
Q1
$19K Sell
244
-56,263
-100% -$4.21M 0.01% 81
2018
Q4
$4.12M Sell
56,507
-783
-1% -$55.3K 3.37% 14
2018
Q3
$3.88M Buy
57,290
+702
+1% +$44.7K 2.92% 18
2018
Q2
$3.28M Sell
56,588
-562
-1% -$31.7K 2.49% 22
2018
Q1
$2.97M Buy
57,150
+192
+0.3% +$10.4K 2.38% 21
2017
Q4
$3.06M Buy
56,958
+252
+0.4% +$14K 2.42% 19
2017
Q3
$3.46M Buy
56,706
+1,083
+2% +$65.7K 2.82% 15
2017
Q2
$3.4M Sell
55,623
-1,167
-2% -$71K 2.89% 16
2017
Q1
$3.44M Sell
56,790
-24,824
-30% -$1.51M 2.91% 17
2016
Q4
$4.58M Buy
81,614
+1,051
+1% +$61.5K 4.16% 9
2016
Q3
$4.8M Sell
80,563
-499
-0.6% -$29.2K 4.43% 7
2016
Q2
$4.46M Sell
81,062
-1,984
-2% -$106K 3.97% 8
2016
Q1
$4.19M Buy
83,046
+750
+0.9% +$36.7K 3.8% 14
2015
Q4
$4.15M Sell
82,296
-733
-0.9% -$37K 4.37% 10
2015
Q3
$3.91M Buy
83,029
+311
+0.4% +$16.5K 3.64% 14
2015
Q2
$4.49M Sell
82,718
-608
-0.7% -$34.1K 4.3% 9
2015
Q1
$4.57M Buy
83,326
+2,892
+4% +$164K 4.03% 10
2014
Q4
$4.36M Sell
80,434
-1,058
-1% -$58.9K 4.04% 13
2014
Q3
$4.61M Buy
81,492
+1,303
+2% +$73.2K 4.37% 8
2014
Q2
$4.43M Sell
80,189
-362
-0.4% -$19.7K 4.33% 9
2014
Q1
$4.36M Sell
80,551
-14,480
-15% -$750K 4.25% 11
2013
Q4
$4.54M Sell
95,031
-799
-0.8% -$36.5K 3.84% 12
2013
Q3
$4.35M Buy
95,830
+1,638
+2% +$74.8K 3.75% 11
2013
Q2
$4.17M Buy
+94,192
New +$4.21M 3.63% 12

Other funds holding MRK

Financial Advantage's MRK Position: Q4 2022 in Review

Financial Advantage sold out of Merck (MRK) in Q4 2022, closing a stake of 1,000 shares — an estimated $86K sold.

Financial Advantage first reported a position in MRK in Q2 2013 and held it in 38 quarters. The position peaked at $4.8M in Q3 2016. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Financial Advantage reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Financial Advantage sold 1,000 Merck shares in Q4 2022, an estimated $86K.
  • Financial Advantage first reported a position in Merck in Q2 2013 and held it in 38 quarters.
  • Financial Advantage's Merck position peaked at $4.8M in Q3 2016.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Financial Advantage's 13F filing for Q4 2022, filed 26 Jan 2023.